Icovamenib Posts HbA1c, C-Peptide Gains in Type 1 Diabetes Trial
Biomea Fusion also flags muscle-preservation and fat-reduction signals, positioning the menin inhibitor as a potential …
Biomea Fusion also flags muscle-preservation and fat-reduction signals, positioning the menin inhibitor as a potential …
Health system AI buildouts are reshaping how ingredient suppliers, clinical researchers, and nutraceutical brands acces…
The episode underscores persistent industry pressure to back cognitive structure-function claims with peer-reviewed cli…
The readout covers tolerability, receptor occupancy, and immunogenicity endpoints — key signals for a mechanism with po…
As GLP-1 weight-loss agents reshape the metabolic health market, lean-mass retention emerges as a key functional differ…
The retraction leaves the regulatory status of Quebec's proposed energy drink age-restriction legislation unclear for C…
The Zachary-Miron Act signals tightening provincial oversight of high-caffeine RTD beverages — a potential model for fe…
Integrative health conferences are increasingly intersecting with functional nutrition — a signal of converging consume…
As honey-matrix delivery formats gain shelf space in the nootropic category, regulators and consumers alike are pressin…
Real-world evidence from a matched Medicare cohort signals a meaningful care-pathway shift for lumbar discogenic pain m…
Findings from the first decentralized, real-world HD chorea study surface patient- and caregiver-reported outcomes — a …
The oral presentation marks a clinical milestone for polyclonal antibody therapies targeting post-transplant viral comp…